Skip to main content
$1.99 $0.05 (2.6%)

04:00 PM EDT on 03/24/23

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $1.99 Mkt Cap $114.2M
Open $1.95 P/E Ratio 0.00
Prev. Close $1.99 Div. (Yield) $0.00 (0.0%)
Daily Range $1.93 - $2.02 Volume 1,111,220
52-Wk Range $0.94 - $2.21 Avg. Daily Vol. 1,003,690

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

148 Outperform
72 Underperform
 

All-Star Players

10 Outperform
22 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (70.76)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

Fools bullish on NYSEMKT:PLX are also bullish on:

Fools bearish on NYSEMKT:PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: +22.74

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -178.43

IHS pattern

Recs

2
Member Avatar TMFBiologyFool (70.76) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +253.41

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (< 20) Score: +735.37

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 98.66 2/10/2009 Underperform 3W $2.66 -24.81% +366.34% +391.15 0 Comment
anticitradeshort 26.79 4/20/2009 Underperform NS $2.27 -11.89% +366.98% +378.88 0 Comment
Spelunkin 26.20 11/3/2009 Underperform 5Y $10.39 -80.75% +281.09% +361.84 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -79.80% +279.66% +359.46 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -79.80% +279.66% +359.46 0 Comment
MSFOBV1YH 95.10 11/4/2009 Underperform 5Y $10.93 -81.70% +274.69% +356.40 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -83.18% +272.05% +355.23 0 Comment
ModernDayWarrior 28.28 10/29/2009 Underperform 5Y $9.58 -79.12% +275.83% +354.96 0 Comment
mathieugp 26.14 9/28/2009 Underperform 3M $7.87 -74.59% +277.05% +351.64 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $12.00 -83.33% +266.23% +349.56 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.